Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

Posts by tag

NAFLD

13 posts
  • This content is machine translated MASLD often goes unnoticed and is underestimated

Think tank for improving the supply situation

Metabolic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), can lead to serious complications. Non-invasive diagnostics and AI-supported screening have the potential to facilitate early detection in...…
View Post
  • 12 min
  • This content is machine translated Liver steatosis with metabolic dysfunction

New nomenclature for non-alcoholic fatty liver disease

The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...…
CME-Test
View Post
  • 12 min
  • This content is machine translated Liver steatosis with metabolic dysfunction

New nomenclature for non-alcoholic fatty liver disease

The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...…
CME-Test
View Post
  • 4 min
  • This content is machine translated From symptom to diagnosis

Abdominal pain – Steatosis hepatis

In steatotic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are distinguished from alcoholic fatty liver disease (AFLD) and alcoholic steatohepatitis (ASH) from an etiological point of…
View Post
  • 4 min
  • This content is machine translated Fibrosis (FIB)-4 score

Screening at-risk patients for NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease. The FIB-4 score can be used to identify at-risk patients with NAFLD and, if necessary, refer them…
View Post
  • 3 min
  • This content is machine translated Fatty liver disease

New widespread disease NAFLD

Model calculations suggest that the number of patients with cirrhosis, advanced fibrosis, or hepatocellular carcinoma (HCC) could double to triple in the next 10-15 years. Not least because of this,…
View Post
  • 5 min
  • This content is machine translated Non-alcoholic fatty liver disease (NAFLD)

What does the current guideline say?

Non-alcoholic fatty liver disease is the most common liver disease worldwide. The German S2k guideline, updated in 2022, recommends screening patients at risk. The proposed screening algorithm includes fibrosis assessment…
View Post
  • 11 min
  • This content is machine translated Non-alcoholic fatty liver disease (NAFLD)

Underdiagnosed and underestimated

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western world. In distinction to alcoholic fatty liver disease, alcohol consumption in NAFLD should be at a…
CME-Test
View Post
  • 3 min
  • This content is machine translated Non-alcoholic fatty liver disease (NAFLD)

No pill will help…

The term non-alcoholic fatty liver disease encompasses a spectrum of findings ranging from simple steatosis or fatty liver to steatohepatitis as an inflammatory form to liver fibrosis and cirrhosis. There…
View Post
  • 2 min
  • This content is machine translated Type 2 diabetes and NAFLD

Large waist circumference increases risk of severe liver damage

Recent study data suggest an association between waist circumference and progression of nonalcoholic fatty liver disease (NAFLD) in people with type 2 diabetes. In NAFLD, fat accumulates in the liver,…
View Post
  • 11 min
  • This content is machine translated Non-alcoholic fatty liver disease (NAFLD)

Underdiagnosed and underestimated

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western world. In distinction to alcoholic fatty liver disease, alcohol consumption in NAFLD should be at a…
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Clinical care from birth to adulthood
  • 2
    Multidisciplinary teams in oncology
  • 3
    Multidisciplinary teams in oncology
  • 4
    What is tested when and on whom?
  • 5
    Molecular mechanisms of tumor plasticity

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.